Cerclage for Twins With Short Cervical Length ≤ 15mm
TWIN-UIC
Cervical Cerclage for Preventing Spontaneous Preterm Birth in Twin Pregnancies With Transvaginal Ultrasound Cervical Length ≤ 15mm: a Study Protocol for a Randomized Clinical Trial
1 other identifier
interventional
200
4 countries
8
Brief Summary
This is a multicenter randomized study designed to determine if ultrasound indicated cerclage reduces the incidence of spontaneous preterm birth \<34 weeks in asymptomatic women with twin gestations and cervical length ≤15mm, diagnosed by transvaginal ultrasound between 16 to 23 6/7 weeks of gestation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2017
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2017
CompletedFirst Submitted
Initial submission to the registry
November 8, 2017
CompletedFirst Posted
Study publicly available on registry
November 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedApril 27, 2020
April 1, 2020
6.9 years
November 8, 2017
April 23, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Preterm delivery less than 34 weeks
Incidence of preterm birth less than 34 weeks (any indication)
at delivery
Secondary Outcomes (11)
Spontaneous preterm birth rates
at delivery
Preterm delivery less than <32 weeks, <28 weeks, or <24 weeks
at delivery
Mean gestational age at delivery
at delivery
Birth weight at birth
at delivery
Gestational age at spontaneous rupture of membranes
at delivery
- +6 more secondary outcomes
Study Arms (2)
Cervical cerclage + vaginal progesterone
ACTIVE COMPARATORCervical cerclage in twin pregnancy with transvaginal cervical length ≤15mm and Daily vaginal progesterone 400mg from diagnosis of short cervix to 36 weeks
Vaginal progesterone
NO INTERVENTIONDaily vaginal progesterone 400mg from diagnosis of short cervix to 36 weeks
Interventions
Cervical cerclage indicated by short cervix ≤15mm
Eligibility Criteria
You may qualify if:
- Pregnant women more than 18 years of age (limits the participants to female gender)
- Diamniotic twin pregnancy
- Asymptomatic
- Transvaginal cervical length ≤ 15 mm between 16-23 6/7 weeks gestation
You may not qualify if:
- Singleton or higher order than twins multiple gestation
- Transvaginal cervical length \>15mm
- Cervical dilation with visible amniotic membranes
- Amniotic membranes prolapsed into the vagina
- Fetal reduction after 14 weeks form higher order
- Monoamniotic twins
- Twin-twin transfusion syndrome
- Ruptured membranes
- Major fetal structural anomaly
- Fetal chromosomal abnormality
- Cerclage already in place for other indication
- Active vaginal bleeding
- Clinical chorioamnionitis
- Placenta previa
- Painful regular uterine contractions
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Jefferson Universitylead
- Federico II Universitycollaborator
Study Sites (8)
George Washington University
Washington D.C., District of Columbia, 20052, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
Austin Maternal Fetal Medicine St David's Health Care
Austin, Texas, 78758, United States
The Egyptian IVF Center
Cairo, Egypt
Bologna University
Bologna, Italy
University of Brescia
Brescia, Italy
Università degli Studi di Napoli "Federico II"
Naples, Italy
University of Barcelona
Barcelona, Spain
Related Publications (6)
Hamilton BE, Hoyert DL, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2010-2011. Pediatrics. 2013 Mar;131(3):548-58. doi: 10.1542/peds.2012-3769. Epub 2013 Feb 11.
PMID: 23400611RESULTGoldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, Mercer BM, Meis PJ, Moawad AH, Das A, Caritis SN, McNellis D. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):1047-53. doi: 10.1016/s0002-9378(96)80051-2.
PMID: 8885774RESULTConde-Agudelo A, Romero R, Hassan SS, Yeo L. Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010 Aug;203(2):128.e1-12. doi: 10.1016/j.ajog.2010.02.064. Epub 2010 Jun 23.
PMID: 20576253RESULTSaccone G, Rust O, Althuisius S, Roman A, Berghella V. Cerclage for short cervix in twin pregnancies: systematic review and meta-analysis of randomized trials using individual patient-level data. Acta Obstet Gynecol Scand. 2015 Apr;94(4):352-8. doi: 10.1111/aogs.12600. Epub 2015 Mar 1.
PMID: 25644964RESULTRoman A, Rochelson B, Fox NS, Hoffman M, Berghella V, Patel V, Calluzzo I, Saccone G, Fleischer A. Efficacy of ultrasound-indicated cerclage in twin pregnancies. Am J Obstet Gynecol. 2015 Jun;212(6):788.e1-6. doi: 10.1016/j.ajog.2015.01.031. Epub 2015 Jan 28.
PMID: 25637840RESULTRomero R, Conde-Agudelo A, El-Refaie W, Rode L, Brizot ML, Cetingoz E, Serra V, Da Fonseca E, Abdelhafez MS, Tabor A, Perales A, Hassan SS, Nicolaides KH. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Ultrasound Obstet Gynecol. 2017 Mar;49(3):303-314. doi: 10.1002/uog.17397.
PMID: 28067007RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amanda Roman, MD
Thomas Jefferson University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2017
First Posted
November 13, 2017
Study Start
June 22, 2017
Primary Completion
June 1, 2024
Study Completion
June 1, 2025
Last Updated
April 27, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF